DCF — CENTRAL MAINE MEDICAL CENTER
Enterprise Value: $-351.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-351.0M
Enterprise Value
$-117.4M
PV of Cash Flows
$-233.6M
PV of Terminal Value
$-376.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $408.8M | $-18.4M | -5.0% | $-35.7M | $-32.5M |
| Year 2 | $421.0M | $-14.7M | -4.0% | $-32.6M | $-26.9M |
| Year 3 | $433.7M | $-10.8M | -3.0% | $-29.2M | $-21.9M |
| Year 4 | $446.7M | $-8.9M | -2.0% | $-27.8M | $-19.0M |
| Year 5 | $460.1M | $-8.1M | -2.0% | $-27.5M | $-17.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-351.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$396.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000000251978725
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5